Literature DB >> 24636202

Polymorphism of circadian clock genes and prophylactic lithium response.

Janusz K Rybakowski, Monika Dmitrzak-Weglar, Sebastian Kliwicki, Joanna Hauser.   

Abstract

OBJECTIVES: The therapeutic action of lithium in bipolar mood disorder may be connected with its effect on biological rhythms. In the present study, an attempt was made to investigate an association between multiple single nucleotide polymorphisms (SNPs) and their haplotypes pertaining to four genes involved in regulation of biological rhythms [circadian locomotor output cycle kaput (CLOCK), aryl hydrocarbon receptor nuclear translocator-like (ARNTL), timeless circadian clock (TIMELESS), period circadian clock 3 (PER 3)], and the efficacy of lithium prophylaxis.
METHODS: The study was performed on 115 patients with bipolar mood disorder (45 males, 70 females) with a mean age of 52 ± 12 years, with lithium prophylaxis for 22 ± 8 years, recruited from the outpatients in the Department of Psychiatry, Poznan University of Medical Sciences. The assessment of the lithium prophylactic response was made retrospectively using the Alda scale. Genotyping was done for nine SNPs of the CLOCK gene, 18 SNPs of the ARNTL gene, six SNPs of the timeless circadian clock (TIM) gene, and nine SNPs of the PER3 gene.
RESULTS: An association with the degree of lithium prophylaxis was found for six SNPs and three haplotype blocks of the ARNTL gene, and two SNPs and one haplotype block of the TIM gene. No association with SNPs or haplotypes of the CLOCK and PER3 genes was observed.
CONCLUSIONS: The results suggest that the ARNTL and TIM genes may be associated with the lithium prophylactic response in bipolar illness. This association may be related to the role of these genes in the predisposition to bipolar mood disorder. Of special interest may be polymorphisms of these genes involved both in the predisposition to bipolar mood disorder and the lithium response.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24636202     DOI: 10.1111/bdi.12136

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  9 in total

Review 1.  Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.

Authors:  Gin S Malhi; Tim Outhred
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 2.  The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.

Authors:  Claudia Pisanu; Urs Heilbronner; Alessio Squassina
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 3.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Bernhard T Baune
Journal:  EPMA J       Date:  2017-09-05       Impact factor: 6.543

Review 4.  Circadian Rhythms, Disease and Chronotherapy.

Authors:  Yool Lee; Jeffrey M Field; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2021-09-22       Impact factor: 3.649

Review 5.  Response to lithium in bipolar disorder: clinical and genetic findings.

Authors:  Janusz K Rybakowski
Journal:  ACS Chem Neurosci       Date:  2014-03-25       Impact factor: 4.418

Review 6.  Candidate Risks Indicators for Bipolar Disorder: Early Intervention Opportunities in High-Risk Youth.

Authors:  Anne Duffy; Steven Jones; Sarah Goodday; Richard Bentall
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-25       Impact factor: 5.176

Review 7.  Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.

Authors:  Yeni Kim; Renata Santos; Fred H Gage; Maria C Marchetto
Journal:  Front Cell Neurosci       Date:  2017-02-14       Impact factor: 5.505

8.  Comparative transcriptome analysis and CRISPR/Cas9 gene editing reveal that E4BP4 mediates lithium upregulation of Per2 expression.

Authors:  Qin Zhou; Kankan Wang; Jiameng Qiu; Di Zhu; Tian Tian; Yunfei Zhang; Ximing Qin
Journal:  Open Biol       Date:  2021-12-15       Impact factor: 6.411

Review 9.  Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings.

Authors:  Giselli Scaini; Samira S Valvassori; Alexandre P Diaz; Camila N Lima; Deborah Benevenuto; Gabriel R Fries; Joao Quevedo
Journal:  Braz J Psychiatry       Date:  2020 Sep-Oct       Impact factor: 2.697

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.